Ross Hall Construction Demo Art

Research Highlights

Laboratories in Ross Hall Renovated to Support Growing Research Community at GW School of Medicine and Health Sciences
Laboratories in Ross Hall Renovated to Support Growing Research Community at GW School of Medicine and Health Sciences
Researchers pulling samples

Research Highlights

Research Trends

Augmenting the research portfolio and elevating its prominence through enhanced quality and impact.

Research Trends
Environmental of lab

Research Highlights

Core Facilities

These facilities offer a wide range of services, including cutting-edge technologies and high-end instrumentation coupled with technical support for research.

Core Facilities

hand washing with soapCoronavirus (COVID-19) Update: SMHS Research Re-Start Plans

Visit GW SMHS ON CAMPUS Policies and Guidelines website

 

 

Research News

From left: Moncef Slaoui, PhD, MBA, chief adviser for Operation Warp Speed; GW SMHS Dean Barbara L. Bass, MD; and GW COVID-19 vaccine trial PI DavidDiemert, MD.

Moncef Slaoui, PhD, MBA, chief adviser for the COVID-19 vaccine development initiative Operation Warp Speed, visited GW on Oct. 21 to raise awareness for the national vaccine development efforts, encourage greater participation in the clinical trials and recognize GW for exceeding its enrollment goals for its vaccine trial.

 

photo of Anne Chiaramello, PhD, associate professor of anatomy and cell biology

Anne Chiaramello, PhD, associate professor of anatomy and cell biology and founding director of the Mito-EpiGen Program, discusses the $1.13 million NIH grant she is working on with Andrea Gropman, MD, from Children’s National Hospital, to test a novel therapeutic approach for two rare mitochondrial diseases that occur when mitochondria in cells do not produce enough energy.

The George Washington University School of Medicine and Health Sciences researchers have been awarded a $3.6 million contract to genetically modify commensal organisms to produce antidotes for harmful biological and chemical agents, such as anthrax, Ebola, and even COVID-19.

Research